KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2025)

Acadia Pharmaceuticals has reported Tax Rate over the past 9 years, most recently at 11.68% for Q4 2025.

  • Quarterly results put Tax Rate at 11.68% for Q4 2025, up 93.0% from a year ago — trailing twelve months through Dec 2025 was 1.27% (down 1350.0% YoY), and the annual figure for FY2025 was 1.28%, down 1353.0%.
  • Tax Rate for Q4 2025 was 11.68% at Acadia Pharmaceuticals, up from 60.95% in the prior quarter.
  • Over the last five years, Tax Rate for ACAD hit a ceiling of 82.54% in Q2 2023 and a floor of 60.95% in Q3 2025.
  • Median Tax Rate over the past 5 years was 1.11% (2021), compared with a mean of 5.7%.
  • Biggest five-year swings in Tax Rate: soared 8386bps in 2023 and later plummeted -7652bps in 2025.
  • Acadia Pharmaceuticals' Tax Rate stood at 0.44% in 2021, then crashed by -364bps to 2.04% in 2022, then tumbled by -646bps to 15.25% in 2023, then skyrocketed by 171bps to 10.76% in 2024, then grew by 9bps to 11.68% in 2025.
  • The last three reported values for Tax Rate were 11.68% (Q4 2025), 60.95% (Q3 2025), and 33.69% (Q2 2025) per Business Quant data.